The Industry’s Most Critical Challenges: Is Your Company Prepared?
By

With DCAT Week fast approaching, secure your spot at the DCAT Week education programs to gain valuable insights from senior executives to help your company navigate the industry’s most pressing challenges. Programs have built-in networking opportunities. Be seen and gain answers to these crucial questions from these must-attend programs. 

How will the industry perform in 2023 and in the near term?  

Pharma Industry Outlook 
Monday, March 20, 2023: 2:30 – 4:30 PM; Doors open at 2:00 PM for  networking. Plus Post-Program Attendee Networking Reception: 4:30 to 6:00 PM. 

Graham Lewis
Vice President,

Global Pharma Strategy
IQVIA 

DCAT Week’s flagship program, Pharma Industry Outlook, provides you with need-to-know market intelligence on the current and projected performance of the bio/pharma industry.  Graham Lewis, Vice President of Global Pharma Strategy, IQVIA, a business intelligence firm regarded as the gold standard for bio/pharmaceutical market analysis, will provide the latest market data and trends. Plus, get expert insight from Ernst & Young (EY) on the key trends in industry deal-making and capital flow into Emerging Pharma, a crucial customer base for CDMOs/CMOs and partner for bio/pharma companies. 

Register or learn more about this program here. 

How are can my company further address current market volatility and reduce supply risk?  

Without question, dealing with recent market volatility (inflationary pressures, supply-chain disruptions, and geopolitical uncertainty) has been the number one issue facing the industry. These conditions have resulted in escalating raw materials costs, actual and potential supply risks, and pricing pressures. How is the industry addressing these issues now and in the long term? 

DCAT is bringing in high-level executives to delve deeper and provide practical insights in how to best address these issues by giving multidimensional solution-based views for the industry. 

Executive Insights: Weathering the Storm – The Path Forward in Optimizing Supply Practices 
Tuesday, March 21, 2023: 10:30 – 11:45 AM; Doors open at 10:00 AM for coffee & networking.  

Karin Shanahan 
Executive Vice President,

Global Product Development & Supply,
Bristol-Myers Squibb

Senior executives from Bristol-Myers Squibb, Catalent, and BASF provide a “buy” and “sell”-side  view on  ways to optimize supply practices in light of recent market volatility: inflationary pressures, supply-chain disruptions, and geopolitical uncertainty. Learn from them on the following key questions. What are the new best practices and approaches in contracting? How has supplier evaluation and selection been affected?  What are the risk-mitigation strategies needed now and how can we anticipate the ones that will be necessary in the future? 

Register or learn more about the program here

Industry Radar 2023: Energy, Raw Materials & Sustainability 
Tuesday, March 21, 2023: 2:00 PM – 3:15 PM; Doors open at 1:30 PM for coffee & networking. 

Lisa Martin
Senior Vice President,
Global Procurement and
Chief Procurement Officer, 
GlaxoSmithKline 

The industry is facing two hot-button issues: input costs and sustainability. An energy and chemicals outlook examines the pressure points in raw materials and what can be expected in 2023. Plus, Lisa Martin, Chief Procurement Officer (CPO), GlaxoSmithKline (GSK), provides a CPO view on sustainability and how GSK is working with suppliers to meet sustainability targets. 

Register or learn more about this program here

The Disruption Busters: New Approaches in Supplier Risk Assessment & Mitigation 
Wednesday, March 22, 2023: 10:15 AM – 11:30 AM 

How are other industries dealing with the unprecedented supply-chain challenges of today? The program will provide expert insight from the automotive, tech, and other industries on new approaches/tools in supplier risk assessment and mitigation to build greater supply-chain resiliency.  

This program is presented in partnership with the Axia Institute, a research and education center of Michigan State University (MSU) and part of MSU’s Office of Research and Innovation. The Axia Institute was founded by leaders in value-chain creation and development at MSU, including the Broad College of Business, which is recognized for its top-ranked Supply Chain Management Program (U.S. News & World Report, 2022). DCAT is pleased to also be a partner with MSU’s Broad College of Business and its Supply Chain Management Program. 

Register or learn more about this program here

Senior executives’ long-term vision of supply management 
Research & Benchmarking Executive Summary: Envisioning Bio/Pharma Sourcing and Supply Chain Management in 2030 
Tuesday, March 21, 2023: 8:00 AM – 9:00 AM; Doors open at 7:30 AM for coffee and networking 

Sourcing, procurement, and supply-chain operations are traditionally expected to focus on cost-of-goods and inventories. However, the pandemic and other economic and geopolitical events have highlighted vulnerabilities in bio/pharma supply arrangements and added sustainability as a critical objective. As a result, sourcing and supply-chain management has become more complex and critical, requiring a broader range of skills and capabilities than in the past. 

To help DCAT Member Companies (bio/pharma companies and suppliers) understand how the sourcing and supply-chain management function is evolving and where it is heading, the DCAT Research and Benchmarking Committee conducted a study, Envisioning Bio/Pharma Sourcing and Supply Chain Management in 2030, based on a series of interviews with senior executives. 

This program will provide the key takeaways from the study with executive sharing their vision for the supply-chain organization of the future.   

Register or learn more about this program here